GHRP-2
MODERATE EVIDENCEAlso known as: Pralmorelin
Investigational in most territories — not FDA approved
Educational Overview
A growth-hormone-releasing peptide studied for its GH secretagogue activity; used diagnostically in some jurisdictions.
Research Mechanism
Acts on the ghrelin/GH secretagogue receptor to stimulate pituitary GH release.
Areas of Study
- GH-axis research
- Diagnostic use (non-US)
Safety Considerations
Not FDA approved. Also stimulates cortisol and prolactin release to a degree, unlike more selective secretagogues. Prohibited in competitive sport. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
How do I get pricing?
Request a quote and our team will respond with current pricing and available sizes for your account.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.